11β-hydroxysteroid dehydrogenase types 1 and 2:: An important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids

被引:121
作者
Diederich, S
Eigendorff, E
Burkhardt, P
Quinkler, M
Bumke-Vogt, C
Rochel, M
Seidelmann, D
Esperling, P
Oelkers, W
Bähr, V
机构
[1] Free Univ Berlin, Klinikum Benjamin Franklin, Dept Endocrinol Diabetol & Nutr, D-12200 Berlin, Germany
[2] Schering AG, Res Labs, D-12200 Berlin, Germany
关键词
D O I
10.1210/jc.2002-020970
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The 11beta-hydroxysteroid dehydrogenase (11beta-HSD) system plays a pivotal role in glucocorticoid (GC) and mineralocorticoid (MC) action. Although 11beta-HSD activities are important determinants for the efficacy of synthetic MCs and GCs, corresponding pharmacokinetic data are scanty. Therefore, we characterized 11beta-HSD profiles for a wide range of steroids often used in clinical practice. 11beta-HSD1 and 11beta-HSD2 were selectively examined in 1) human liver and kidney cortex microsomes, and 2) Chinese hamster ovarian cells stably transfected with 11beta-HSDI or 11beta-HSD2 expression vectors. Both systems produced concordant evidence for the following conclusions. Oxidation of steroids by 11beta-HSD2 is diminished if they are fluorinated in position 6alpha or 9alpha (e.g. in dexamethasone) or methylated at 2alpha or 6alpha (in methylprednisolone) or 16alpha or 16beta, by a methylene group at 16 (in prednylidene), methyloxazoline at 16, 17 (in deflazacort), or a 2-chlor configuration. Whereas the methyl groups also decrease reductase activity (steric effects), fluorination increases reductase activity (negative inductive effect), leading to a shift to reductase activity. This may explain the strong MC activity of 9alpha-fluorocortisol and should be considered in GC therapy directed to 11beta-HSD2-expressing tissues (kidney, colon, and placentofetal unit). 11beta-HSD2 oxidation of prednisolone is more effective than that of cortisol, explaining the reduced MC activity of prednisolone compared with cortisol. Reduction by 11beta-HSD1 is diminished by 16alpha-methyl, 16beta-methyl, 2alpha-methyl, and 2-chlor substitution, whereas it is increased by the Delta(1)-dehydro configuration in prednisone, resulting in higher hepatic first pass activation of prednisone compared with cortisone. To characterize a GC or a MC as substrate for the different 11betaHSDs may be essential for an optimized steroid therapy.
引用
收藏
页码:5695 / 5701
页数:7
相关论文
共 33 条
[1]   GENE STRUCTURE AND CHROMOSOMAL LOCALIZATION OF THE HUMAN HSD11K GENE ENCODING THE KIDNEY (TYPE-2) ISOZYME OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE [J].
AGARWAL, AK ;
ROGERSON, FM ;
MUNE, T ;
WHITE, PC .
GENOMICS, 1995, 29 (01) :195-199
[2]   General overview of mineralocorticoid hormone action [J].
Agarwal, MK ;
Mirshahi, M .
PHARMACOLOGY & THERAPEUTICS, 1999, 84 (03) :273-326
[3]  
ASSANDRI A, 1984, ADV EXP MED BIOL, V171, P9
[4]   RADIORECEPTOR ASSAY FOR EVALUATION OF PLASMA GLUCOCORTICOID ACTIVITY OF NATURAL AND SYNTHETIC STEROIDS IN MAN [J].
BALLARD, PL ;
CARTER, JP ;
GRAHAM, BS ;
BAXTER, JD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 41 (02) :290-304
[5]   Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs.: Discovery of potent and selective inhibitors of the 11β-hydroxysteroid dehydrogenase type 1 [J].
Barf, T ;
Vallgårda, J ;
Emond, R ;
Häggström, C ;
Kurz, G ;
Nygren, A ;
Larwood, V ;
Mosialou, E ;
Axelsson, K ;
Olsson, R ;
Engblom, L ;
Edling, N ;
Rönquist-Nii, Y ;
Öhman, B ;
Alberts, P ;
Abrahmsén, L .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (18) :3813-3815
[6]   Human 11 beta-hydroxysteroid dehydrogenase: Studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue [J].
Bujalska, O ;
Shimojo, M ;
Howie, A ;
Stewart, PM .
STEROIDS, 1997, 62 (01) :77-82
[7]   METABOLISM OF 11-OXYGENATED STEROIDS .2. 2-METHYL STEROIDS [J].
BUSH, IE ;
MAHESH, VB .
BIOCHEMICAL JOURNAL, 1959, 71 :718-742
[8]   METABOLISM OF 11-OXYGENATED STEROIDS - METABOLISM IN VITRO BY PREPARATIONS OF LIVER [J].
BUSH, IE ;
HUNTER, SA ;
MEIGS, RA .
BIOCHEMICAL JOURNAL, 1968, 107 (02) :239-&
[9]   Metabolism of synthetic corticosteroids by 11β-hydroxysteroid-dehydrogenases in man [J].
Diederich, S ;
Hanke, B ;
Burkhardt, P ;
Müller, M ;
Schöneshöfer, M ;
Bähr, V ;
Oelkers, W .
STEROIDS, 1998, 63 (5-6) :271-277
[10]   Metabolism of dexamethasone in the human kidney: Nicotinamide adenine dinucleotide-dependent 11 beta-reduction [J].
Diederich, S ;
Hanke, B ;
Oelkers, W ;
Bahr, V .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (05) :1598-1602